BioScrip, Inc. (BIOS) Misses Q1 EPS by 4c; Guides Above for FY
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Price: $10.80 --0%
Financial Fact:
Amortization of intangibles: 4.17M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Amortization of intangibles: 4.17M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioScrip, Inc. (NASDAQ: BIOS) reported Q1 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $155.6 million versus the consensus estimate of $143.44 million.
BioScrip, Inc. sees FY2012 revenue of $600-$620 million, versus the consensus of $586.34 million.
For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.
BioScrip, Inc. sees FY2012 revenue of $600-$620 million, versus the consensus of $586.34 million.
For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Hitachi Ltd. (HIT) Misses Q2 EPS by 7c
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
